Prognostic significance of occult lymph node metastases in node-negative breast cancer

Annals of Surgical Oncology

Volumn 4, Issue 6, 1997, Pages 447-451

  Clare, Susan E ^b   Sener, Stephen F ^a   Wilkens, William ^b   Goldschmidt, Robert ^b   Merkel, Douglas ^b   Winchester, David J ^b  

^a EVANSTON HOSPITAL   (United States)

^b NONE

Author keywords

Breast cancer; Cytokeratin (antikeratin) antibodies; Occult metastases

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; EOSIN; HEMATOXYLIN; KERATIN; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CHEMISTRY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH NODE; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE;

BREAST NEOPLASMS; COLORING AGENTS; DISEASE-FREE SURVIVAL; EOSINE YELLOWISH-(YS); FEMALE; FOLLOW-UP STUDIES; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031229951     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303667     Document Type: Article

References (21)

1. Valgussa P, Bonadonna G, Veronesi V. Patterns of relapse and survival following radical mastectomy. Cancer 1978;41:1170-8.
2. Fisher B, Slack N, Katrych D, et al. Ten year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 1975;140:528-34.
3. Nemoto T, Vana J, Bedwani R, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-24.
4. Andersson I, Aspergren K, Janzon L, et al. Mammographic screening and mortality from breast cancer. The Malmo mammographic screening trial. Br Med J 1988;297:943-8.
5. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast cancer. Surg Gynecol Obstet 1970;131:79-88.
6. Merkel DE, Winchester DJ, Rademaker AW, et al. DNA flow cytometry and pathologic grading as prognostic guides in node-negative breast cancer. Cancer 1993;72:1926-32.
7. Fisher B, Bauer M, Wickerham L, et al. Relationship of the number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983;52:1151-7.
8. Saphir O, Amromin GD. Obscure axillary lymph node metastases in carcinoma of breast. Cancer 1948;1:238-41.
9. Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer 1961;14:1266-71.
10. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978;42:2025-31.
11. Wilkinson EJ, Hause LL, Hoffman RG, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 1982;17:67-91.
12. Rosen PP, Saigo PE, Braun DW Jr, et al. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli. Am J Surg Pathol 1982;6:639-41.
13. Wells CA, Heryet J, Brochier J, et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50:193-7.
14. Bussolati G, Gugliotta P, Morra I, et al. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1986;54:631-6.
15. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987;55:303-6.
16. Trojani M, de Mascarel I, Coindre JM, et al. Micrometastases to axillary lymph nodes from invasive lobular carcinoma of the breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987;56:838-9.
17. Sedmak DD, Meineke TA, Knechtges DS, et al. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2:516-20.
18. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-8.
19. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993;80:459-63.
20. Nasser IA, Lee AKC, Bosari S, et al. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993;24:950-7.
21. Guiliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-9.